SCHEDULE 13G/A: Millennium Entities Update Passive Stake in BioAtla, Inc. to 1.9%
Beneficial Ownership Disclosure
Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander have jointly filed an amended Schedule 13G, reporting a passive beneficial ownership of 1.9% in BioAtla, Inc.'s common stock as of December 31, 2024.
Summary
- Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander have filed an Amendment No. 1 to Schedule 13G regarding their beneficial ownership in BioAtla, Inc.
- As of December 31, 2024, the reporting persons collectively beneficially own 1,095,606 shares of BioAtla, Inc.'s Common Stock.
- This aggregate amount represents 1.9% of BioAtla, Inc.'s outstanding Common Stock.
- The reporting persons hold shared voting power and shared dispositive power over all 1,095,606 shares.
- The filing certifies that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer, indicating a passive investment intent.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership, which is neutral in sentiment. It provides transparency but does not inherently indicate positive or negative developments for the company beyond the fact of institutional investment.
Positives
- The disclosure indicates that a significant institutional investor, Millennium Management, holds a stake in BioAtla, Inc., which can be viewed as a vote of confidence in the company's long-term prospects by a sophisticated investor.
Future Outlook
The document is a disclosure of current beneficial ownership and does not contain any forward-looking statements or guidance regarding BioAtla, Inc.'s future performance or strategic direction.
Industry Context
This filing is a routine disclosure of institutional ownership in the biotechnology sector. The presence of a hedge fund like Millennium Management as a passive investor is common and provides transparency into the shareholder base of publicly traded companies.
Stakeholder Impact
- Shareholders: Provides transparency regarding significant institutional ownership, allowing them to understand who holds a stake in the company.
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date of event which requires the filing of this statement (beneficial ownership calculation date). |
| 01/23/2025 | Date of filing of the Schedule 13G/A and the Joint Filing Agreement. |
Keywords
BioAtla Inc., Millennium Management LLC, Millennium Group Management LLC, Israel A. Englander, Schedule 13G/A, beneficial ownership, common stock, institutional investment, passive stake
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.